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Abstract
Background: Hip and knee osteoarthritis is a common cause of pain and disability, which can be
improved by exercise interventions. However, regular exercise is uncommon in this group because
the low physical activity level in the general population is probably reduced even further by pain
related fear of movement. The best method of encouraging increased activity in this patient group
is not known. A booklet has been developed for patients with hip or knee osteoarthritis. It focuses
on changing disadvantageous beliefs and encouraging increased physical activity.
Methods/Design: This paper describes the design of a Phase II randomised controlled trial (RCT)
to test the effectiveness of this new booklet for patients with hip and knee osteoarthritis in
influencing illness and treatment beliefs, and to assess the feasibility of conducting a larger definitive
RCT in terms of health status and exercise behaviour. A computerised search of four general
medical practice patients' record databases will identify patients older than 50 years of age who
have consulted with hip or knee pain in the previous twelve months. A random sample of 120 will
be invited to participate in the RCT comparing the new booklet with a control booklet, and we
expect 100 to return final questionnaires. This trial will assess the feasibility of recruitment and
randomisation, the suitability of the control intervention and outcome measurement tools, and will
provide an estimate of effect size. Outcomes will include beliefs about hip and knee pain, beliefs
about exercise, fear avoidance, level of physical activity, health status and health service costs. They
will be measured at baseline, one month and three months.
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Discussion:  We discuss the merits of testing effectiveness in a phase II trial, in terms of
intermediate outcome measures, whilst testing the processes for a larger definitive trial. We also
discuss the advantages and disadvantages of testing the psychometric properties of the primary
outcome measures concurrently with the trial.
Trial registration: Current Controlled Trials ISRCTN24554946
Background
Systematic reviews have highlighted the effectiveness of
exercise in reducing pain and disability in hip and knee
osteoarthritis [1-4] and recent guidelines have empha-
sised the central role of exercise in the management of
osteoarthritis [5,6]. Both aerobic walking and muscle
strengthening exercise have been shown to be effective;
however the optimal type, dose and setting for such phys-
ical activity is uncertain [3,7]. Despite these benefits, long-
term adherence to exercise regimes is disappointing, and
if exercise is not maintained its beneficial effects decline
over time and finally disappear [8]. The level of physical
activity in older adults in the United Kingdom is low [9-
12], and reduced further by pain related fear of movement
in those with osteoarthritis [13,14]. Indeed, there is a cul-
turally conditioned response to pain that encourages rest,
which is inappropriate for most with this problem. How
can osteoarthritis patients be encouraged to increase their
physical activity? In the similar field of low back pain an
evidence-based patient advice booklet ('The Back Book'
[15]) designed to encourage activity was found to be effec-
tive in changing patients' beliefs and behaviours. The
effectiveness of this 'Back Book' was demonstrated in
three randomised controlled trials (RCTs) [16-18], one of
which involved older people.
Developing 'The Hip and Knee Book'
We have developed a similar booklet encouraging
increased activity in patients with hip or knee osteoarthri-
tis. The theoretical framework underpinning this new
booklet is Leventhal's theory of self regulation, which
states that our coping response to illness is governed by
our beliefs about the nature of the illness: how well we
understand the symptoms (its identity), its chronicity, its
controllability, its cause, and the seriousness of its conse-
quences [19]. Educational interventions should empha-
sise that control is possible and within individuals'
capabilities. This model has been extended to include
treatment beliefs, so that when considering an interven-
tion patients weigh up the perceived benefit in health gain
with the perceived cost in terms of pain, fear and expecta-
tion of exacerbating the condition [20]. In addition, social
learning theory states that an individual's ability to per-
form an activity (self-efficacy) is crucial to behaviour
change [21]. The evidence based messages for this booklet
were obtained from a review of systematic reviews and
evidence based management guidelines. These were then
converted into patient centred messages and combined in
the narrative of a draft booklet. This draft booklet was
examined in four focus groups of patients with hip or
knee osteoarthritis, which improved the phrasing and
emphasis of the patient centred messages in the final
booklet [22]. The development of this booklet has been
described in more detail elsewhere [23]. This paper
reports upon the design of a RCT to test the effectiveness
of this new booklet for patients with hip and knee oste-
oarthritis in terms of influencing illness and treatment
beliefs, and to assess the feasibility of conducting a larger




This study has several overlapping aims. In order to test
the effectiveness of the new 'Hip and Knee Book' for
changing illness and treatment related beliefs a RCT
design is employed using outcome measures designed to
measure such beliefs. We also want to assess the feasibility
of conducting a future definitive RCT and concurrent eco-
nomic evaluation of the effectiveness and cost-effective-
ness of this new booklet on health status and exercise
behaviour, so we will use this RCT to pilot recruitment
and retention of participants recruited from primary care
with hip or knee osteoarthritis, measure changes in health
status, levels of physical activity and public agency costs.
The results will inform the sample size calculation for a
future Phase III RCT. We have developed instruments
measuring illness and treatment beliefs from outcome
measures designed for different purposes, so we will use
this RCT to concurrently test the validity and responsive-
ness of these adapted instruments.
Recruitment
Practice and participant selection
Participants will be recruited from four general medical
practices in Wrexham and Flintshire in North East Wales
in the United Kingdom. Patients with hip and knee oste-
oarthritis will be identified by searching the practices'
computerised patient record database for the relevant
Read codes (Table 1). Anonymised unique patient identi-
fication numbers will be downloaded onto an Excel file
and sent to the trial statistician, who will select a random
sample of 400 patients with hip and knee osteoarthritis
from all four practices. Additional patients will be placedBMC Family Practice 2009, 10:62 http://www.biomedcentral.com/1471-2296/10/62
Page 3 of 9
(page number not for citation purposes)
on a reserve list. The Excel file containing the anonymised
patient identification numbers will be returned to the
practice management team, who will check that the
patients fulfil the inclusion and exclusion criteria and that
it is appropriate to invite them to participate in the study.
Patients who are ineligible, or where an invitation to par-
ticipate would be inappropriate, will be replaced by those
on the reserve list. The practice management team will
send eligible patients invitation letters to participate,
signed by their general practitioner (GP) on the practices'
headed note paper, including an information sheet about
the trial and a consent form. We will invite the initial 400
sample to participate, and those on the reserve list as nec-
essary, until we have reached our target of 120 partici-
pants (Figure 1).
Inclusion and exclusion criteria
Patients over 50 years old presenting in primary care with
hip or knee osteoarthritis within the last 12 months will
be included. Specific diagnostic criteria for osteoarthritis
will not be used as these are inconsistently applied in pri-
mary care populations. Exclusion criteria will be inflam-
Participant flow diagram Figure 1
Participant flow diagram.
Search of computerised records in 4 general medical practices using criteria: 
>50 years old, consulting with hip or knee osteoarthritis in previous 12 months 
Random sample  
400 invited to participate in study by written invitation from their general 
practitioner
Recruitment 
120 recruited (30% recruitment rate) sent baseline postal questionnaire 
Remote 
Randomisation 
60 participants sent ‘The Hip and 
Knee Book’ 
60 participants sent the control 
booklet
One month follow-up   One month follow-up  
Postal questionnaire sent one month 
after randomisation
Postal questionnaire sent one month 
after randomisation
Three months follow-up   Three months follow-up  
Postal questionnaire sent three 
months after randomisation 
Postal questionnaire sent three 
months after randomisation 
50 returned (if response rate 80%)  50 returned (if response rate 80%) BMC Family Practice 2009, 10:62 http://www.biomedcentral.com/1471-2296/10/62
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matory joint disease, fractures, arthroplasty referral, and
prescription of potent opioid analgesia. Patients who have
already participated in the focus groups used to develop
the new booklet will be excluded from the trial.
Informed consent
Patients will be sent an information sheet about the trial
along with their letter of invitation and a consent form.
The contact details of the research assistant co-ordinating
recruitment will be included, and participants will be
encouraged to ask for more information if they require it.
The information sheet, letter of invitation and consent
form will emphasise that patients' clinical care will remain
unaffected whether they accept or decline to participate.
Registration and non-registration
Once the consent form has been returned to the trial man-
ager (EA) at the trial office participant details will be
recorded on an Access database and assigned a unique
trial code. Anonymised details labelled with the unique
trial code will be transferred to a separate database which
will be used for recording all of the trial results. This will
ensure that outcome measurement and statistical analysis
will be performed blind to treatment allocation. All data-
bases will be password protected. Eligible patients who
are not part of the random sample will not be contacted
and will not be invited to participate. Patients who return
consent forms but decline the invitation to participate will
be recorded anonymously. Completed consent forms will
be stored in a locked filing cabinet.
Withdrawal & loss to follow-up
We anticipate that 100 out of the 120 (80%) participants
recruited will return their final questionnaires. Participant
withdrawal from the study will not affect their medical
care, and this point will be emphasised in the patient
information sheet.
Timing of randomisation
All units from a practice (block) will be recruited prior to
randomisation. Randomisation will be undertaken by the
trial statistician (JB) using information supplied on the
baseline questionnaire.
Study intervention
Participants randomised to the intervention arm will be
sent the new educational booklet by mail. This booklet
'The Hip and Knee Book: helping you cope with osteoar-
thritis' [22] describes the development of osteoarthritis as
a dynamic process with the potential for some repair and
discourages the more passive concept of 'wear and tear'.
Physical activity is emphasised as being beneficial for
arthritic joints, as well as for general physical health, and
a variety of different types of exercise are promoted.
Patients are also encouraged to lose weight if overweight,
use simple analgesia and anti-inflammatory gels. Pre-
scribed medication and additional methods to control
pain are described. The role of different therapists is dis-
cussed as are specialist treatments including arthroplasty.
The booklet emphasises that control over their condition
is possible and within individuals' capabilities.
Participants randomised to the control arm will be sent a
patient information booklet about osteoarthritis pro-
duced by the Arthritis Research Campaign (ARC) [25],
which can be obtained from the ARC website, and is
widely available in rheumatology out-patient clinics. This
booklet discusses the mechanism of osteoarthritis, treat-
ment options and self-management. Physical activity and
exercise is mentioned, but not emphasised. In particular,
it does not address the same exercise-related beliefs and
behaviours as the intervention booklet. Clinical care of
patients will not be affected or influenced in any other
manner by participating in the study.
Outcome measures
Primary outcome measures
The primary outcomes will be illness and treatment
beliefs. Illness beliefs will be measured with the Hip and
Knee Beliefs Questionnaire (HKBQ). This has been mod-
ified from the Backs Beliefs Questionnaire (BBQ) [26],
and measures beliefs regarding the progressive nature of
hip and knee osteoarthritis. Treatment beliefs will be
Table 1: Read codes for eligible patients (>50 years old)
Included Read codes




N094K arthralgia of hip




N04 (and below) inflammatory polyarthropathy
7K2 (and below) hip joint operations
7K3 (and below) knee joint operationsBMC Family Practice 2009, 10:62 http://www.biomedcentral.com/1471-2296/10/62
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measured with a modified Exercise Attitude Question-
naire-18 (EAQ-18) [27]. We have demonstrated the face
validity of these questionnaires in semi-structured inter-
views using cognitive de-briefing [28]. We will collect data
on the reliability, validity and responsiveness of these
modified questionnaires concurrently with the trial anal-
ysis. Using a transition question we will place those who
report no change into a reliability analysis and those who
do report change into a responsiveness analysis.
Secondary outcome measures
These will include:
• International Physical Activity Questionnaire
(IPAQ) [29], a measure of physical activity over the
previous seven days in terms of vigorous activities
(heavy lifting, digging, aerobics, fast bicycling), mod-
erate activities (carrying light loads, bicycling at a reg-
ular pace, doubles tennis), walking and sitting;
￿ Tampa Scale for Kinesiophobia (TSK) [Miller R, Kori
S, Todd D. Unpublished report; 1991], a measure of
fear-avoidance beliefs that has been used in osteoar-
thritis populations [30];
￿ Western Ontario McMaster universities Arthritis
index (WOMAC) [31], a condition-specific outcome
measure for osteoarthritis, which has sub-scales for
pain, stiffness and disability;
￿ SF-12 [32], a generic outcome measure that provides
a physical summary score and a mental summary
score that can be compared across different illnesses
and patient groups;
￿ EuroQol EQ-5D [33], a measure of health utility that
can be used to calculate Quality Adjusted Life Years
(QALYs) for a cost-utility analysis in an economic
evaluation;
￿ Client Service Receipt Inventory (CSRI) [34,35], a
measure of health service activity such as contact with
health professionals in the community (general prac-
titioners, nurse, health care assistants and others),
tests or investigations, contact with secondary care
health professionals (hospital doctors, specialist
nurses and therapists), hospital services (accident and
emergency, day surgery and in-patients) and medica-
tion, which can be combined with published national
unit costs to measure costs for the economic evalua-
tion;
￿ Adverse effects of the booklets collected as written
comments at the end of the final questionnaire.
Trial procedures
Postal questionnaires
The questionnaires will follow best practice in their design
to maximise response rate [36]. In particular, the ques-
tionnaire design will be: aesthetically pleasing using col-
oured ink; as short as possible; accompanied by a
personalised letter using the university letter head; and
sent by first class mail. Non-responders will be contacted
by telephone, and sent a second copy of the questionnaire
if required. Postal questionnaires will be sent at baseline,
after one and three months, in Teleform® format to allow
scanning of responses into a computerised database. All
data will be anonymised and coded so that data collection
and statistical analysis will be blinded to treatment alloca-
tion.
Health economic data collection
Health economic costs will be measured from a National
Health Service (NHS) perspective. Health service activity
will be collected from responses to the CSRI incorporated
into the final patient questionnaire. Patients will be asked
about the type and frequency of contact with primary and
secondary healthcare services over the three month
period. Unit costs will be obtained from national sources
[37] and local finance officers.
Randomisation
Randomisation will balance the two groups by site of
pain, age, gender and duration of symptoms. As all
patients are consented prior to randomisation, this will
use an optimal allocation approach proposed by Raab
[38] and algorithms developed by Carter [39]. Patients
will be recruited from each practice and then randomised
as a block. Within the block all potential allocations to
two groups will be calculated and their balance statistic
calculated. The 1% with the nearest optimal balance will
be passed to an independent statistician who will ran-
domly select the allocation for use and randomly allocate
groups. The balance calculations for subsequent blocks
will incorporate the degree of balance for the chosen allo-
cation to ensure close to optimal balance across groups.
Sample size
In order to detect a moderate to large effect size of 0.55 in
change in illness and treatment beliefs, with 80% power
and a significance level of 5%, a sample size of 100 will be
needed. We anticipate that 30% of those invited will agree
to participate, and 80% of those recruited will return their
final questionnaires; so that 400 patients will need to be
sent letters inviting them to participate, 120 will be
recruited, and 100 will return final questionnaires.
Trial analysis
All data will be anonymised and coded so that data collec-
tion and statistical analysis is blinded to treatment alloca-BMC Family Practice 2009, 10:62 http://www.biomedcentral.com/1471-2296/10/62
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tion. The code will only be broken after the main analysis
has been completed.
Main analysis
Statistical analysis of the primary outcome measures
HKBQ and EAQ-18 will be based on an intention to treat
analysis using repeated measures analysis of covariance
(ANCOVA). This method adjusts each patient's follow up
score for his or her baseline measurements. Data transfor-
mations such as taking logarithms may be appropriate
and any missing values can be imputed using regression
techniques. The analysis will be expanded to include addi-
tional prognostic variables for exploratory analysis. There
are assumptions underlying the ANCOVA model which
include normality of residuals, equal variances, linearity,
and independence. These assumptions will be tested, in
particular the homogeneity of regression assumptions.
Analysis of secondary outcomes
Statistical analysis of the secondary outcome measures
IPAQ, TSK, WOMAC, SF-12, EQ-5D will also be based on
an intention to treat analysis using repeated measures
ANCOVA. The effect size of WOMAC and IPAQ will
inform the sample size calculation for a future phase III
trial.
Assessment of feasibility of the phase III trial
Feasibility will be assessed by process measures of: the
numbers of eligible participants identified, contacted and
recruited with reasons for non-inclusion; the numbers of
participants retained by the trial at one month and three
months.
Psychometric testing of the modified outcome measures
The modified HKBQ and the modified EAQ-18 will be
tested concurrently within the trial using criteria devel-
oped by Streiner and Norman [40].
Reliability will be measured in terms of internal consist-
ency and test-retest reliability. Internal consistency will be
measured using Cronbach's alpha on the baseline scores.
This will be considered too low if below 0.7 and too high
if greater than 0.9 to avoid item redundancy. Test-retest
reliability will be assessed by comparing the baseline
questionnaire with the retest questionnaires at one and
three months. Transition questions to assess change in ill-
ness or treatment beliefs will be used with each follow up
questionnaire. Those reporting that their beliefs were
unchanged will be included in a test-retest analysis by cal-
culating an intra-class correlation co-efficient (ICC) [41],
and by calculating limits of agreement according to the
method of Bland and Altman [42].
Construct validity will be assessed by comparing baseline
with repeat questionnaires, if the transition questions
indicate that beliefs have changed. Changes in beliefs will
also be compared with changes in behaviour as measured
by the physical activity questionnaire, and with changes in
health status as measured by WOMAC and SF-12.
Responsiveness will be measured using the modified
standardised response mean. The numerator of this statis-
tic will be change in score when the transition question
reports that beliefs have changed; the denominator will be
the standard deviation of the change score when beliefs
are unchanged [43].
Cost effectiveness analysis
Mean health care costs of service use by patients in the
control and intervention groups will be calculated and
compared using non-parametric bootstrapping. Health
economic analysis will initially involve a cost-conse-
quences analysis of all the costs and outcomes collected
[35]. We will calculate a bootstrapped incremental cost
utility ratio (ICUR) point estimate of the cost per Quality
Adjusted Life Year (QALY) to be gained from this inter-
vention as compared with the control, using EQ-5D as a
source of utility weights [33]. We will use bootstrapping
to generate a cost-utility acceptability curve to inform pol-
icy makers of the probability that the intervention is cost-
effective [35,44]. We will compare our estimate of the cost
per QALY with the ceiling of £30,000 used by NICE.
Given the relatively small sample size for this Phase II
RCT, the findings will give a useful indication of the
approximate size of the cost per QALY ratio for this inter-
vention. It will inform the sample size calculation for a
sufficiently powered future definitive RCT and concurrent
economic evaluation. This trial platform offers an oppor-
tunity to compare EQ-5D values with SF-12 values and the
other outcome measures of the trial in order to make
some assessment of its sensitivity and appropriateness for
use in a full trial [45].
Ethical approval
Ethical approval was obtained from the North Wales East
Research Ethics Committee [REC reference 09/WNo03/5].
Discussion
A number of issues arise from our use of this phase II trial
to not only test the processes for a larger definitive trial,
but also to assess effectiveness in terms of intermediate
outcomes and concurrently validate the primary outcome
measures.
Testing the effectiveness of intermediate outcomes
From our theoretical framework for developing 'The Hip
and Knee Book' we have presumed that people with OA
knee or hip have unhelpful beliefs and fears which are
responsible for increasing their level of disability. We
hypothesise that reading the new booklet, and not theBMC Family Practice 2009, 10:62 http://www.biomedcentral.com/1471-2296/10/62
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control booklet, will alter their illness and exercise-related
beliefs (measured by HKBQ and EAQ-18 respectively),
reduce their fear of movement (measured by TSK), change
their behaviour to increase their physical activity (meas-
ured by IPAQ), which will in turn reduce pain, stiffness
and disability (measured by the condition-specific out-
come measure WOMAC) and lead to improved general
health status (measured by SF-12) and health utility
(measured by EQ-5D). Outcomes measuring links higher
up this theoretical chain are likely to be more responsive
than links further down. Definitive or phase III trials need
primary outcomes measuring health status or health util-
ity, which are 'downstream', less responsive and require
larger sample sizes. For this smaller phase II trial we have
presumed that their will be a larger change in more
'upstream' intermediate outcomes such as illness and
treatment-related beliefs. The position of these outcome
measures in this theoretical chain can be debated. It may
be that before illness and treatment beliefs change partic-
ipants' fear of movement must be addressed. Alternatively
change in participants' views about the prognosis of their
arthritic condition, and the benefit of exercise, may lead to
a reduction in the fear of movement. Self-efficacy is also
important in changing behaviour such as exercise.
Although we did not include a separate measure of self-
efficacy so as not to over-burden our participants, some of
the individual items in the EAQ-18 outcome measure do
address this.
Assessing feasibility for a larger phase III trial
According to the Medical Research Council's guidance for
developing and evaluating complex interventions [24] the
piloting stage includes: testing procedures for delivering
the intervention, estimating the likely rates of recruitment
and retention of participants, and estimating the effect
size of the primary outcome measure in preparation for a
sample size calculation. We have also taken the opportu-
nity of testing outcomes measuring beliefs which we
hypothesise will have a larger effect size than outcomes
measuring behaviours or health status.
Concurrent psychometric testing of outcome measures
The HKBQ has been adapted from the Back Beliefs Ques-
tionnaire [BBQ], which is a measure of patients' beliefs
about the inevitable consequences of back pain, and was
shown to be responsive to change in a previous RCT of
'The Back Book' [46]. It has also been adapted to become
the Whiplash Beliefs Questionnaire, which has undergone
psychometric testing [47]. A similar instrument for hip
and knee OA is not available, so we decided to adapt the
BBQ for this purpose. We believe that the risk that such an
adapted outcome measure will not be reliable, valid or
responsive is less than that if it were to be constructed de
novo. Whilst the ideal situation would be to test its psycho-
metric properties for this different population before
using it in a trial; we took the pragmatic decision to vali-
date it concurrently with the phase II trial. We have used
this approach successfully in other previous studies
[47,48]. The questionnaire is being administered with an
intervention, which we hope will alter the outcome meas-
ures being tested, so the conditions are not ideal for
assessing test-retest reliability. However, we will attempt
to obtain some evidence about reliability by collecting
data on those participants who claim that there is no
change according to an accompanying transition ques-
tion. Of course patients' responses to these outcome
measures may shift independently of any trial interven-
tion, in response to behavioural, cognitive and affective
processes necessary to accommodate any chronic illness
[49]. So long as these processes influence the outcome
measures and transition question in a consistent manner,
they should not interfere with the concurrent psychomet-
ric testing.
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